Evidence map›Paper›PMID 24813807›Full record

ArticleCancer genetics2014

Analysis of the t(3;8) of hereditary renal cell carcinoma: a palindrome-mediated translocation.

Takema Kato, Colleen P Franconi, Molly B Sheridan, April M Hacker, Hidehito Inagakai, Thomas W Glover, Martin F Arlt, Harry A Drabkin, Robert M Gemmill, Hiroki Kurahashi and 1 more

Open access · greenAbstract read
In one paragraph

Article in Cancer genetics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Palindromes in DNA-A Risk for Genome Stability and Implications in Cancer.International journal of molecular sciences · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Takema KatoDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Colleen P FranconiDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Molly B SheridanDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
April M HackerDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Hidehito InagakaiDivision of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan.
Thomas W GloverDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Martin F ArltDepartment of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
Harry A DrabkinDivision of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA.
Robert M GemmillDivision of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA.
Hiroki KurahashiDivision of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan.
Beverly S EmanuelDivision of Human Genetics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; Department of Pediatrics, The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. Electronic address: beverly@mail.med.upenn.edu.
Children's Hospital of Philadelphia · USFujita Health University · JPMedical University of South Carolina · USUniversity of Michigan–Ann Arbor · US

Funding

2/2 Brain, Behavior and Genetic Studies of the 22q11 Deletion StudiesU01MH087636 · NIMH · CHILDREN'S HOSP OF PHILADELPHIA · PI EMANUEL, BEVERLY S · 2010 to 2014
$4.6M
CYTOGENETIC AND MOLECULAR STUDIES OF HUMAN CHROMOSOME 22R01CA039926 · NCI · CHILDREN'S HOSP OF PHILADELPHIA · PI EMANUEL, BEVERLY S · 1985 to 2013
$4.0M
NCI NIH HHS CA039926NCI NIH HHS R01 CA039926NIMH NIH HHS U01 MH087636
6 · The paper itself

Abstract

It has emerged that palindrome-mediated genomic instability generates DNA-based rearrangements. The presence of palindromic AT-rich repeats (PATRRs) at the translocation breakpoints suggested a palindrome-mediated mechanism in the generation of several recurrent constitutional rearrangements: the t(11;22), t(17;22), and t(8;22). To date, all reported PATRR-mediated translocations include the PATRR on chromosome 22 (PATRR22) as a translocation partner. Here, the constitutional rearrangement, t(3;8)(p14.2;q24.1), segregating with renal cell carcinoma in two families, is examined. The chromosome 8 breakpoint lies in PATRR8 in the first intron of the RNF139 (TRC8) gene, whereas the chromosome 3 breakpoint is located in an AT-rich palindromic sequence in intron 3 of the FHIT gene (PATRR3). Thus, the t(3;8) is the first PATRR-mediated, recurrent, constitutional translocation that does not involve PATRR22. Furthermore, we detect de novo translocations similar to the t(11;22) and t(8;22), involving PATRR3 in normal sperm. The breakpoint on chromosome 3 is in proximity to FRA3B, the most common fragile site in the human genome and a site of frequent deletions in tumor cells. However, the lack of involvement of PATRR3 sequence in numerous FRA3B-related deletions suggests that there are several different DNA sequence-based etiologies responsible for chromosome 3p14.2 genomic rearrangements.

Indexed as

Translocation, GeneticAcid Anhydride HydrolasesAnimalsAT Rich SequenceBase SequenceBis(5'-adenosyl)triphosphataseCarcinoma, Renal CellCell LineChromosome BreakpointsChromosomes, Human, Pair 3Chromosomes, Human, Pair 8HumansInverted Repeat SequencesKidney NeoplasmsMaleMiceAcid Anhydride HydrolasesBis(5'-adenosyl)triphosphataseNeoplasm ProteinsReceptors, Cell SurfaceRNF139 protein, humanFRA3BPalindromePATRRrenal cell carcinomatranslocation

Identifiers

PMID24813807
PMCPMC4102306
OpenAlexW1982575744

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.